239 related articles for article (PubMed ID: 15105118)
1. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Steinbach WJ; Schell WA; Blankenship JR; Onyewu C; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2004 May; 48(5):1664-9. PubMed ID: 15105118
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Steinbach WJ; Singh N; Miller JL; Benjamin DK; Schell WA; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2004 Dec; 48(12):4922-5. PubMed ID: 15561883
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.
Lamoth F; Juvvadi PR; Gehrke C; Steinbach WJ
Antimicrob Agents Chemother; 2013 Feb; 57(2):1035-9. PubMed ID: 23165466
[TBL] [Abstract][Full Text] [Related]
4. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.
Kontoyiannis DP; Lewis RE; Osherov N; Albert ND; May GS
J Antimicrob Chemother; 2003 Feb; 51(2):313-6. PubMed ID: 12562696
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus.
Steinbach WJ; Cramer RA; Perfect BZ; Henn C; Nielsen K; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2979-81. PubMed ID: 17502415
[TBL] [Abstract][Full Text] [Related]
6. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Gao L; Ding X; Liu Z; Wu Q; Zeng T; Sun Y
Antimicrob Agents Chemother; 2016 Jun; 60(6):3813-6. PubMed ID: 26976874
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus.
Falloon K; Juvvadi PR; Richards AD; Vargas-Muñiz JM; Renshaw H; Steinbach WJ
PLoS One; 2015; 10(9):e0137869. PubMed ID: 26366742
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.
Del Poeta M; Cruz MC; Cardenas ME; Perfect JR; Heitman J
Antimicrob Agents Chemother; 2000 Mar; 44(3):739-46. PubMed ID: 10681348
[TBL] [Abstract][Full Text] [Related]
11. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
[TBL] [Abstract][Full Text] [Related]
13. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
[TBL] [Abstract][Full Text] [Related]
14. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
MacCallum DM; Whyte JA; Odds FC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Ganesan LT; Manavathu EK; Cutright JL; Alangaden GJ; Chandrasekar PH
Clin Microbiol Infect; 2004 Nov; 10(11):961-6. PubMed ID: 15521997
[TBL] [Abstract][Full Text] [Related]
17. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
[TBL] [Abstract][Full Text] [Related]
18. Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
Manavathu EK; Alangaden GJ; Chandrasekar PH
J Antimicrob Chemother; 2003 Jun; 51(6):1423-5. PubMed ID: 12716776
[TBL] [Abstract][Full Text] [Related]
19. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
20. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
